These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6720291)

  • 21. Reduction of immediate complications after panretinal photocoagulation.
    Liang JC; Huamonte FU
    Retina; 1984; 4(3):166-70. PubMed ID: 6494634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Techniques of argon laser photocoagulation of diabetic disk new vessels.
    Little HL; Zweng HC; Jack RL; Vassiliadis A
    Am J Ophthalmol; 1976 Nov; 82(5):675-83. PubMed ID: 1033672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can photoreceptor loss also account for changes in pupil size following panretinal photocoagulation?
    Najjar RP; Milea D
    Eye (Lond); 2017 Jan; 31(1):161. PubMed ID: 27689962
    [No Abstract]   [Full Text] [Related]  

  • 24. [Subretinal neovessels of the posterior pole after pan-photocoagulation for diabetic retinopathy].
    Bacin F; Pujo-Chincholle A
    Bull Soc Ophtalmol Fr; 1986 Nov; 86(11):1385-6, 1388. PubMed ID: 2438061
    [No Abstract]   [Full Text] [Related]  

  • 25. Xenon arc photocoagulation of proliferative diabetic retinopathy. A review of 2688 consecutive eyes in the format of the Diabetic Retinopathy Study.
    Okun E; Johnston GP; Boniuk I; Arribas NP; Escoffery RF; Grand MG
    Ophthalmology; 1984 Dec; 91(12):1458-63. PubMed ID: 6084216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative trial of xenon arc and argon laser photocoagulation in the treatment of proliferative diabetic retinopathy.
    Plumb AP; Swan AV; Chignell AH; Shilling JS
    Br J Ophthalmol; 1982 Apr; 66(4):213-8. PubMed ID: 6175340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reply to 'Can photoreceptor loss also account for changes in pupil size following panretinal photocoagulation?'.
    Yilmaz I; Ozkaya A
    Eye (Lond); 2017 Jan; 31(1):161-162. PubMed ID: 27716749
    [No Abstract]   [Full Text] [Related]  

  • 28. Xenon arc and argon laser photocoagulation in the treatment of diabetic disc neovascularization. Part 2. Effect on colour vision.
    Birch J; Hamilton AM
    Trans Ophthalmol Soc U K (1962); 1981; 101(1):93-9. PubMed ID: 6192563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficiency comparison of the argon laser and the high-pressure xenon arc lamp in the treatment of diabetic retinopathy by photocoagulation. II. Clinical results].
    Fankhauser F; Lotmar W; Roulier A
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1972; 184(2):111-25. PubMed ID: 4537605
    [No Abstract]   [Full Text] [Related]  

  • 30. Dilated pupils and loss of accommodation following diode panretinal photocoagulation with sub-tenon local anaesthetic in four cases.
    Patel JI; Jenkins L; Benjamin L; Webber S
    Eye (Lond); 2002 Sep; 16(5):628-32. PubMed ID: 12194080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A study of the mechanisms of transient myopia following extensive xenon arc photocoagulation.
    Boulton PE
    Trans Ophthalmol Soc U K (1962); 1973; 93(0):287-300. PubMed ID: 4526450
    [No Abstract]   [Full Text] [Related]  

  • 32. Dye yellow vs. argon green laser in panretinal photocoagulation for proliferative diabetic retinopathy: a comparison of minimum power requirements.
    Castillejos-Rios D; Devenyi R; Moffat K; Yu E
    Can J Ophthalmol; 1992 Aug; 27(5):243-4. PubMed ID: 1393811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathologic correlation of xenon arc and argon laser photocoagulation. Procedure in human diabetic eyes.
    Wallow IH; Davis MD
    Arch Ophthalmol; 1979 Dec; 97(12):2308-15. PubMed ID: 574760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Photocoagulation treatment of proliferative diabetic retinopathy: relationship of adverse treatment effects to retinopathy severity. Diabetic retinopathy study report no. 5.
    Dev Ophthalmol; 1981; 2():248-61. PubMed ID: 7262408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of argon laser photocoagulation on rubeosis iridis and angle neovascularization.
    Tasman W; Magargal LE; Augsburger JJ
    Ophthalmology; 1980 May; 87(5):400-2. PubMed ID: 6157141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of xenon arc and argon laser photocoagulation in the treatment of choroidal melanomas.
    Shields JA; Glazer LC; Mieler WF; Shields CL; Gottlieb MS
    Am J Ophthalmol; 1990 Jun; 109(6):647-55. PubMed ID: 2346193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Argon laser photocoagulation.
    Okun E; Boniuk I; Johnston GP
    Mod Probl Ophthalmol; 1972; 10():628-35. PubMed ID: 5066480
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinicopathologic correlation of krypton red, argon blue-green, and argon green laser photocoagulation in the human fundus.
    Smiddy WE; Fine SL; Green WR; Glaser BM
    Retina; 1984; 4(1):15-21. PubMed ID: 6539496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on intravitreal blood vessels. II. Effectiveness of xenon arc and argon laser photocoagulation in blood vessel closure.
    Peyman GA; Koziol JE; Sanders DR; Vlchek JK
    Invest Ophthalmol; 1974 Jun; 13(6):441-54. PubMed ID: 4857574
    [No Abstract]   [Full Text] [Related]  

  • 40. Grand mal seizure during argon laser panretinal photocoagulation.
    Duffey RJ
    Am J Ophthalmol; 1987 Jan; 103(1):116-7. PubMed ID: 3099580
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.